GlobeNewswire

Proficio Disrupts Cybersecurity Industry with "First Year Free" Services Program

Dela

One year of cybersecurity services through Proficio's global security operations centers will be available to 30 select organizations

CARLSBAD, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Proficio(TM), one of the world's fastest growing global managed security service providers (MSSP) delivering managed detection and response (MDR), today announced "First Year Free," a limited-time promotion for select new clients. The exclusive offer provides a free first year of managed security services, including global 24x7 monitoring and alerting.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/9650b5a4-b798-43d4-ba5c-a5124f373d54

Proficio's goal is to help companies manage the increasing cost and scarcity of needed cybersecurity resources to achieve a fully protected environment. The program also allows organizations that are unsatisfied with their current MSSP to make a switch, regardless of contract terms and timelines. The program is exclusively available to the first 30 qualified clients.  For terms and details, visit: www.proficio.com/first-year-free.

"The security landscape is complex and challenging - an understatement, given the number of moving parts that are involved in defending an enterprise from cyberattacks. Organizations are struggling to find proactive and predictive security solutions," states Martha Vazquez, Senior Research Analyst, Infrastructure Services at IDC. "Protection comes at a steep price, and many companies are outsourcing their cybersecurity to managed security services providers (MSSPs) to offset increasing costs and leverage the external MSSP's expertise. Proficio's offer gives executives an opportunity to outsource their security needs without significant upfront costs, making it easier to switch existing vendors or kickstart a new program."

Proficio provides a range of cybersecurity services, from 24x7 monitoring and alerting, to incident response and cybersecurity consulting, through their global security operations centers (SOC) in San Diego, Barcelona and Singapore. Proficio is recognized in the industry for its white-glove service, customizable solution packages, automated response capabilities, and alert accuracy.

"Proficio is fully committed to providing innovative solutions to our clients," said Tim McElwee, Proficio's President and Chairman of the Board. "That requires creative thinking in all areas of our business which is how we've been successful. Organizations need real solutions that address their individual needs, and this new program certainly makes world-class cybersecurity services attainable."

"The marketplace was speaking loudly and our leadership team chose to take action," stated Dustin Ritter, Chief Marketing Officer at Proficio. "Organizations know they're vulnerable and are looking for an immediate solution. Unfortunately, most cybersecurity leaders find themselves in one of two positions: they either lack the internal resources to handle threats effectively and don't have a budget, or they are unhappy with their current services provider but are hindered by contract constraints. This program was specifically created to remove these hurdles that obstruct complete cyber protection."

About Proficio:
Founded in 2010, Proficio offers the full range of cybersecurity services including managed detection and response (MDR), 24x7 monitoring and alerting, security assessments, and consulting through global security operations centers. Proficio's innovative approach to managed cybersecurity services helps organizations defend against advanced threats.

Media Contact:
media@proficio.com
800-779-5042




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Proficio, Inc. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum